LUOYANG FUDAU BIOTECH CO.LTD.--Cell Culture Consumables

  In the dynamic world of serum storage, the choice of containers plays a pivotal role in preserving the integrity and efficacy of blood serum. Enter   PETG Media Bottles , a game-changer for blood serum manufacturers seeking a reliable and innovative solution for storage. Preserving Purity: PETG, a high-performance polymer, forms the foundation of these media bottles. Its inert nature ensures that the stored blood serum remains unaltered, preserving its purity and preventing any leaching of contaminants. This is especially critical for serum manufacturers aiming to deliver consistently high-quality products. Secure Seal for Longevity: Equipped with precision-fit caps, PETG Media Bottles create an airtight seal, shielding the blood serum from external influences. The secure seal not only maintains the longevity of the serum but also prevents the risk of contamination, ensuring that the serum's composition remains intact throughout storage. PETG Media Bottles Clarity for Qualit...

  In the realm of laboratory liquid storage, the choice of containers plays a pivotal role in maintaining the integrity and quality of stored substances. Enter   PETG Media Bottles   with Caps, a versatile solution designed to elevate the storage of culture media, buffers, and other essential liquids. Precision in Liquid Preservation: PETG, a high-performance polymer, forms the foundation of these media bottles. Its inherent qualities ensure a reliable and secure environment for the storage of sensitive liquids. The transparency of PETG allows for easy visual inspection, ensuring the preservation of the liquid's original state. Seal of Protection: Equipped with secure caps, these bottles create a robust seal, safeguarding the contents against contaminants. This is especially crucial when storing delicate substances like cell culture media and buffers, where maintaining purity is paramount. The airtight seal also prevents evaporation and maintains the stability of the stor...

  November 8, 2023, the U.S. Food and Drug Administration (FDA) has approved Fruzaqla™ (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy. Fruzaqla is the first and only selective inhibitor of all three VEGF receptor kinases approved in the U.S. for previously treated mCRC regardless of biomarker status.1,2 This approval was received under Priority Review more than 20 days ahead of the scheduled PDUFA date of November 30, 2023. "There is a pressing need for new treatments for individuals with metastatic colorectal cancer, who have had limited options and continue to face poor outcomes. Fruzaqla is the first novel chemotherapy-free treatment option approved for patients in the U.S. regardless of biomarker status in more than a decade,” said Teres...

  November 09, 2023, the U.S. Food and Drug Administration approved Ixchiq, the first chikungunya vaccine. Ixchiq is approved for individuals 18 years of age and older who are at increased risk of exposure to chikungunya virus. The chikungunya virus is primarily transmitted to people through the bite of an infected mosquito. Chikungunya is an emerging global health threat with at least 5 million cases of chikungunya virus infection reported during the past 15 years. The highest risk of infection is in tropical and subtropical regions of Africa, Southeast Asia, and parts of the Americas where chikungunya virus-carrying mosquitos are endemic. However, chikungunya virus has spread to new geographical areas causing a rise in global prevalence of the disease.  The most common symptoms of chikungunya include fever and joint pain. Other symptoms may include a rash, headache, and muscle pain. Some individuals may experience debilitating joint pain that persists for months or even year...

  In the world of laboratory research, precision and reliability are paramount. When it comes to storing crucial solutions like serum culture media, choosing the right container is key.   PETG media bottles   stand out as an exceptional choice, offering a range of material characteristics that ensure both safety and efficacy. Material Excellence: PETG, short for Polyethylene Terephthalate Glycol, is a high-grade polymer renowned for its outstanding material properties. Its biocompatibility ensures that stored solutions remain uncontaminated and free from interference, guaranteeing the integrity of your research. Clarity and Transparency: One of the standout features of PETG media bottles is their exceptional clarity. This allows for easy visual inspection of the contents, a critical aspect when dealing with sensitive solutions like serum culture media. Researchers can monitor the state and quality of their cultures without any distortion or cloudiness. PETG Media Bottles ...

  PETG Media Bottles   are the flagship products offered by our company, catering to the specific needs of cell culture applications. In this article, we will delve into the exceptional biocompatibility of PETG Media Bottles, showcasing their ability to maintain the integrity and viability of cultured cells. Superior Biocompatibility: PETG Media Bottles are selected materials in the field of cell culture due to their remarkable biocompatibility. These bottles are designed to minimize interactions with cultured cells, ensuring their growth and functionality remain unaffected. 1.Reduced Leachables and Extractables:  PETG Media Bottles undergo rigorous testing to ensure the absence of leachables and extractables that may compromise cell cultures. Our bottles are manufactured using high-quality PETG resin, which exhibits excellent stability and minimal release of contaminants into the media. PETG Media Bottles 2.Non-Toxic Material: PETG is widely regarded as a safe and non-to...

  In the realm of pharmaceutical manufacturing, precision and quality are paramount. At FuDau Bio, we take immense pride in presenting our signature product - PETG Media Bottles. These innovative containers are revolutionizing the pharmaceutical industry by ensuring the highest standards of quality and performance. In this article, we will explore the invaluable role that   PETG Media Bottles   play in pharmaceutical applications. 1. Unparalleled Pharmaceutical Quality Assurance Pharmaceutical products must meet rigorous quality standards to guarantee safety and effectiveness. PETG Media Bottles are engineered to meet these exacting requirements. Their exceptional clarity and chemical resistance make them the ideal choice for storing and transporting pharmaceutical ingredients and final products. This ensures that the integrity and quality of pharmaceutical formulations remain uncompromised. 2. Safe and Reliable Storage Solutions Pharmaceutical manufacturing often involve...

  FuDau, a leading enterprise dedicated to providing high-quality cell culture consumables, is proud to announce the launch of its product:   PETG Media Bottles . This groundbreaking product aims to meet the demands of researchers and laboratory professionals, offering exceptional quality and performance. Product Highlights: 1.Advantages of PETG Material: PETG (Polyethylene Terephthalate Glycol) is a robust and shatterproof material that ensures the durability and reliability of the product. This material not only withstands the test of time but also maintains its stability under temperature fluctuations. 2.Various Capacities to Choose From: FuDau's PETG Media Bottles provide a range of capacity options, from 5 milliliters to 1 liters, to cater to various laboratory needs. 3.Superior Sealing: Each bottle comes with a secure and leak-resistant cap, ensuring the cleanliness and contamination-free storage and usage of media. 4.Transparency: The transparency of PETG allows users t...

In the field of cell culture consumables, choosing the right type of bottle for storing and handling media is crucial. Two common options are   PETG (Polyethylene Terephthalate Glycol) media bottles   and glass media bottles. This article aims to provide a comparative analysis of these two choices, focusing on the advantages of PETG media bottles, our core product. 1.Material Differences: PETG Media Bottles: PETG is a type of plastic known for its durability, chemical resistance, and transparency. PETG media bottles are lightweight and shatterproof, making them an excellent choice for shipping and handling. They also have excellent gas barrier properties, reducing the risk of contamination. Glass Media Bottles: Glass media bottles are known for their traditional appearance and the ability to maintain the integrity of the stored contents. However, they are fragile and prone to breakage, which can lead to safety hazards and contamination concerns. 2.Impact on Cell Culture: PETG ...

  In the world of cell culture, the storage and preservation of cell culture media are critical to maintaining the viability and functionality of cells. At FuDau Bio, we understand the importance of reliable and contamination-free media storage solutions. Our   PETG Media Bottles   have emerged as the optimal choice for this purpose, and this article explores their essential role in cell culture media storage. Unveiling the Potential of PETG Media Bottles Material Excellence: Our PETG Media Bottles are crafted from high-quality polyethylene terephthalate glycol (PETG). This material is chosen for its exceptional attributes, such as transparency, durability, and non-reactivity with cell culture media. This ensures that your stored media remains uncontaminated and retains its quality. Exceptional Transparency: PETG Media Bottles' transparency is an invaluable feature for media storage. It enables you to visually inspect the media without exposing it to potential contaminant...

  PETG (Polyethylene Terephthalate Glycol) media bottles offer several advantages, making them a popular choice for various applications in laboratories, pharmaceutical companies, and other industries. Here are some of the key advantages of   PETG media bottles : 1.Transparency: PETG is a clear and transparent material, allowing for easy visual inspection of the contents. This is important in laboratory and medical settings where the accurate measurement and observation of liquids is crucial. 2.Chemical Resistance: PETG bottles are resistant to a wide range of chemicals, including many solvents, acids, and bases. This makes them suitable for storing a variety of solutions without fear of material degradation or leaching into the contents. 3.Impact Resistance: PETG is a tough and impact-resistant plastic. It can withstand accidental drops and rough handling, reducing the risk of breakage and potential contamination of the contents. 4.Lightweight: PETG bottles are lightweight, m...

Serum, as a good assistant in cell culture, plays an important role in the growth process of cells. The quality of serum directly affects the results of cell culture. If there is too much precipitation, it will inevitably cause concern. So, how do we avoid precipitation in   petg media bottles ? First of all, we should have a correct understanding of precipitation. When turbid and flocculent substances are found after thawing the serum, there is no need to panic. This is a normal phenomenon. Common deposits include fibrin, calcium phosphate, cholesterol, fatty acid esters, and some proteins. The amount of serum sedimentation is not directly proportional to the quality of the serum. If serum precipitation occurs, don’t worry. Usually, centrifuge at 400-600g for 5 minutes to remove large particle precipitation, and then use the supernatant. PETG Media Bottles Of course, if you still feel uneasy, you can take the following measures to avoid precipitation in the petg media bottles as m...

  PETG media bottles   are a plastic storage container with high transparency, which are generally used to store serum, culture medium, buffer solution and other solutions. In order to avoid microbial contamination caused by the packaging, it will be sterilized, and this packaging is mainly sterilized by cobalt 60. Sterilization is to ensure the removal or killing of all bacteria, viruses, fungi and other microorganisms on the PETG media bottles by various physical and chemical means, so as to achieve a sterility assurance level of 10-6, that is, to ensure the survival of microorganisms on an item The probability is only one in a million. Only in this way can microorganisms on the packaging be prevented from causing additional contamination of the contents. PETG Media Bottles Cobalt 60 sterilization is the use of 60Co γ-ray irradiation to act on microorganisms, directly or indirectly destroying the nucleus of microorganisms, thereby killing microorganisms and playing the role ...

  PETG media bottles   are a special packaging for storing various media, reagents, serum and other solutions, and it is also a product that scientific researchers have more contact with. The wide range of applications is mainly due to the superior properties of its materials. PETG is a transparent plastic that belongs to the non-crystalline copolyester. Serum needs to be stored in a low temperature environment. The use range of this material is -80°C to 60°C, which makes PETG media bottles fully meet the storage needs of serum. In addition, it has the following features: 1. High transparency, the light transmittance reaches 90%, which can reach the transparency of plexiglass; 2. It has stronger rigidity and hardness, excellent scratch resistance, impact resistance and toughness, which is close to or even exceeds that of polycarbonate (PC), and is suitable for injection molding, extrusion molding and extrusion blowing processing; 3. In terms of chemical resistance, oil resista...

  August 24, 2023, The U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of multiple sclerosis (MS). Tyruko, like Tysabri, is also indicated for inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn’s Disease (CD) with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of TNF-α (tumor necrosis factor, a substance in your body that causes inflammation). “Biosimilar medications offer additional effective treatment options that have the potential to increase access for people living with relapsing forms of multiple sclerosis,” said Paul R. Lee, M.D., Ph.D., director of the Division of Neurology 2 in the FDA’s Center for Drug Evaluation and Research. “Today’s approval could have a meaningful impact for patients mana...

  August 24, 2023, The U.S. Food and Drug Administration today approved Tyruko (natalizumab-sztn), the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of multiple sclerosis (MS). Tyruko, like Tysabri, is also indicated for inducing and maintaining clinical response and remission in adult patients with moderately to severely active Crohn’s Disease (CD) with evidence of inflammation who have had an inadequate response to, or are unable to tolerate, conventional CD therapies and inhibitors of TNF-α (tumor necrosis factor, a substance in your body that causes inflammation). “Biosimilar medications offer additional effective treatment options that have the potential to increase access for people living with relapsing forms of multiple sclerosis,” said Paul R. Lee, M.D., Ph.D., director of the Division of Neurology 2 in the FDA’s Center for Drug Evaluation and Research. “Today’s approval could have a meaningful impact for patients mana...

  July 20, 2023 --(BUSINESS WIRE)--Daiichi Sankyo (TSE: 4568) today announced that Vanflyta (quizartinib) has been approved by the U.S. Food and Drug Administration (FDA) in combination with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following consolidation chemotherapy, for the treatment of adult patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3-ITD positive as detected by an FDA-approved test. Vanflyta is not indicated as maintenance monotherapy following allogeneic hematopoietic stem cell transplantation (HSCT); improvement in overall survival with Vanflyta in this setting has not been demonstrated. AML is one of the most common forms of leukemia in adults and an estimated 20,380 new cases will be diagnosed in the U.S. in 2023.1 Up to 37% of newly diagnosed patients with AML have a FLT3 gene mutation and approximately 80% of these are FLT3-ITD mutations, which drive cancer growth and contribu...